nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP1A2—Dacarbazine—sarcoma	0.0193	0.567	CbGbCtD
Moclobemide—CYP1A2—Etoposide—sarcoma	0.00944	0.277	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—sarcoma	0.0053	0.156	CbGbCtD
Moclobemide—Ill-defined disorder—Dactinomycin—sarcoma	0.00499	0.00516	CcSEcCtD
Moclobemide—Agitation—Thiotepa—sarcoma	0.00497	0.00515	CcSEcCtD
Moclobemide—Dysarthria—Doxorubicin—sarcoma	0.00488	0.00505	CcSEcCtD
Moclobemide—Stomatitis—Etoposide—sarcoma	0.00485	0.00502	CcSEcCtD
Moclobemide—Malaise—Dactinomycin—sarcoma	0.00485	0.00502	CcSEcCtD
Moclobemide—Hypertension—Thiotepa—sarcoma	0.00467	0.00484	CcSEcCtD
Moclobemide—Myalgia—Thiotepa—sarcoma	0.00461	0.00477	CcSEcCtD
Moclobemide—Anxiety—Thiotepa—sarcoma	0.00459	0.00475	CcSEcCtD
Moclobemide—Dysgeusia—Mitoxantrone—sarcoma	0.00458	0.00474	CcSEcCtD
Moclobemide—Myalgia—Dactinomycin—sarcoma	0.00457	0.00474	CcSEcCtD
Moclobemide—Discomfort—Dactinomycin—sarcoma	0.00452	0.00468	CcSEcCtD
Moclobemide—Confusional state—Thiotepa—sarcoma	0.00445	0.00461	CcSEcCtD
Moclobemide—Agitation—Vincristine—sarcoma	0.00441	0.00457	CcSEcCtD
Moclobemide—Vision blurred—Mitoxantrone—sarcoma	0.00441	0.00456	CcSEcCtD
Moclobemide—Ill-defined disorder—Mitoxantrone—sarcoma	0.00434	0.00449	CcSEcCtD
Moclobemide—Tachycardia—Thiotepa—sarcoma	0.00431	0.00446	CcSEcCtD
Moclobemide—Malaise—Mitoxantrone—sarcoma	0.00422	0.00436	CcSEcCtD
Moclobemide—Flushing—Etoposide—sarcoma	0.00415	0.00429	CcSEcCtD
Moclobemide—Hypertension—Vincristine—sarcoma	0.00414	0.00429	CcSEcCtD
Moclobemide—Myalgia—Vincristine—sarcoma	0.00409	0.00423	CcSEcCtD
Moclobemide—Hypertension—Mitoxantrone—sarcoma	0.00404	0.00418	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00403	0.00417	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.004	0.00414	CcSEcCtD
Moclobemide—Chest pain—Mitoxantrone—sarcoma	0.00398	0.00412	CcSEcCtD
Moclobemide—Myalgia—Mitoxantrone—sarcoma	0.00398	0.00412	CcSEcCtD
Moclobemide—Paraesthesia—Thiotepa—sarcoma	0.00397	0.00411	CcSEcCtD
Moclobemide—Anxiety—Mitoxantrone—sarcoma	0.00397	0.00411	CcSEcCtD
Moclobemide—Discomfort—Mitoxantrone—sarcoma	0.00393	0.00407	CcSEcCtD
Moclobemide—Somnolence—Thiotepa—sarcoma	0.00393	0.00407	CcSEcCtD
Moclobemide—Dyspepsia—Thiotepa—sarcoma	0.00389	0.00403	CcSEcCtD
Moclobemide—Hot flush—Epirubicin—sarcoma	0.00387	0.00401	CcSEcCtD
Moclobemide—Confusional state—Mitoxantrone—sarcoma	0.00385	0.00398	CcSEcCtD
Moclobemide—Decreased appetite—Thiotepa—sarcoma	0.00384	0.00398	CcSEcCtD
Moclobemide—Menopausal symptoms—Epirubicin—sarcoma	0.00384	0.00397	CcSEcCtD
Moclobemide—Decreased appetite—Dactinomycin—sarcoma	0.00381	0.00395	CcSEcCtD
Moclobemide—Fatigue—Thiotepa—sarcoma	0.00381	0.00394	CcSEcCtD
Moclobemide—Dysgeusia—Etoposide—sarcoma	0.00381	0.00394	CcSEcCtD
Moclobemide—Hyperhidrosis—Vincristine—sarcoma	0.00379	0.00392	CcSEcCtD
Moclobemide—Fatigue—Dactinomycin—sarcoma	0.00378	0.00391	CcSEcCtD
Moclobemide—Constipation—Thiotepa—sarcoma	0.00378	0.00391	CcSEcCtD
Moclobemide—Shock—Mitoxantrone—sarcoma	0.00375	0.00389	CcSEcCtD
Moclobemide—Tachycardia—Mitoxantrone—sarcoma	0.00372	0.00386	CcSEcCtD
Moclobemide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00369	0.00382	CcSEcCtD
Moclobemide—Hypotension—Vincristine—sarcoma	0.00366	0.00379	CcSEcCtD
Moclobemide—Feeling abnormal—Thiotepa—sarcoma	0.00364	0.00377	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—sarcoma	0.00362	0.00375	CcSEcCtD
Moclobemide—Feeling abnormal—Dactinomycin—sarcoma	0.00361	0.00374	CcSEcCtD
Moclobemide—Gastrointestinal pain—Thiotepa—sarcoma	0.00361	0.00374	CcSEcCtD
Moclobemide—Ill-defined disorder—Etoposide—sarcoma	0.00361	0.00374	CcSEcCtD
Moclobemide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00359	0.00371	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—sarcoma	0.00358	0.00371	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00357	0.0037	CcSEcCtD
Moclobemide—Hypotension—Mitoxantrone—sarcoma	0.00357	0.00369	CcSEcCtD
Moclobemide—Migraine—Epirubicin—sarcoma	0.00356	0.00369	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—sarcoma	0.00355	0.00367	CcSEcCtD
Moclobemide—Insomnia—Vincristine—sarcoma	0.00354	0.00367	CcSEcCtD
Moclobemide—Paraesthesia—Vincristine—sarcoma	0.00352	0.00364	CcSEcCtD
Moclobemide—Urticaria—Thiotepa—sarcoma	0.00351	0.00363	CcSEcCtD
Moclobemide—Malaise—Etoposide—sarcoma	0.00351	0.00363	CcSEcCtD
Moclobemide—Abdominal pain—Thiotepa—sarcoma	0.00349	0.00362	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00348	0.0036	CcSEcCtD
Moclobemide—Abdominal pain—Dactinomycin—sarcoma	0.00347	0.00359	CcSEcCtD
Moclobemide—Paraesthesia—Mitoxantrone—sarcoma	0.00343	0.00355	CcSEcCtD
Moclobemide—Loss of consciousness—Etoposide—sarcoma	0.00342	0.00354	CcSEcCtD
Moclobemide—Decreased appetite—Vincristine—sarcoma	0.00341	0.00353	CcSEcCtD
Moclobemide—Dyspnoea—Mitoxantrone—sarcoma	0.0034	0.00352	CcSEcCtD
Moclobemide—Somnolence—Mitoxantrone—sarcoma	0.00339	0.00351	CcSEcCtD
Moclobemide—Fatigue—Vincristine—sarcoma	0.00338	0.0035	CcSEcCtD
Moclobemide—Dyspepsia—Mitoxantrone—sarcoma	0.00336	0.00348	CcSEcCtD
Moclobemide—Hypertension—Etoposide—sarcoma	0.00336	0.00348	CcSEcCtD
Moclobemide—Constipation—Vincristine—sarcoma	0.00335	0.00347	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—sarcoma	0.00335	0.00347	CcSEcCtD
Moclobemide—Dry skin—Epirubicin—sarcoma	0.00332	0.00343	CcSEcCtD
Moclobemide—Decreased appetite—Mitoxantrone—sarcoma	0.00332	0.00343	CcSEcCtD
Moclobemide—Chest pain—Etoposide—sarcoma	0.00331	0.00343	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—sarcoma	0.0033	0.00341	CcSEcCtD
Moclobemide—Fatigue—Mitoxantrone—sarcoma	0.00329	0.00341	CcSEcCtD
Moclobemide—Discomfort—Etoposide—sarcoma	0.00327	0.00339	CcSEcCtD
Moclobemide—Constipation—Mitoxantrone—sarcoma	0.00326	0.00338	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vincristine—sarcoma	0.0032	0.00332	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—sarcoma	0.0032	0.00332	CcSEcCtD
Moclobemide—Confusional state—Etoposide—sarcoma	0.0032	0.00331	CcSEcCtD
Moclobemide—Asthenia—Thiotepa—sarcoma	0.00317	0.00328	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—sarcoma	0.00315	0.00326	CcSEcCtD
Moclobemide—Asthenia—Dactinomycin—sarcoma	0.00315	0.00326	CcSEcCtD
Moclobemide—Feeling abnormal—Mitoxantrone—sarcoma	0.00314	0.00325	CcSEcCtD
Moclobemide—Pruritus—Thiotepa—sarcoma	0.00313	0.00324	CcSEcCtD
Moclobemide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00312	0.00323	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—sarcoma	0.0031	0.00321	CcSEcCtD
Moclobemide—Abdominal pain—Vincristine—sarcoma	0.0031	0.00321	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—sarcoma	0.00307	0.00318	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—sarcoma	0.00307	0.00318	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—sarcoma	0.00305	0.00315	CcSEcCtD
Moclobemide—Urticaria—Mitoxantrone—sarcoma	0.00303	0.00314	CcSEcCtD
Moclobemide—Diarrhoea—Thiotepa—sarcoma	0.00302	0.00313	CcSEcCtD
Moclobemide—Abdominal pain—Mitoxantrone—sarcoma	0.00302	0.00312	CcSEcCtD
Moclobemide—Diarrhoea—Dactinomycin—sarcoma	0.003	0.00311	CcSEcCtD
Moclobemide—Hypotension—Etoposide—sarcoma	0.00297	0.00307	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—sarcoma	0.00296	0.00307	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—sarcoma	0.00293	0.00303	CcSEcCtD
Moclobemide—Dizziness—Thiotepa—sarcoma	0.00292	0.00302	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—sarcoma	0.00291	0.00302	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—sarcoma	0.00285	0.00295	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—sarcoma	0.00283	0.00293	CcSEcCtD
Moclobemide—Somnolence—Etoposide—sarcoma	0.00282	0.00292	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—sarcoma	0.00282	0.00292	CcSEcCtD
Moclobemide—Asthenia—Vincristine—sarcoma	0.00281	0.00291	CcSEcCtD
Moclobemide—Vomiting—Thiotepa—sarcoma	0.00281	0.00291	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—sarcoma	0.00279	0.00289	CcSEcCtD
Moclobemide—Vomiting—Dactinomycin—sarcoma	0.00279	0.00289	CcSEcCtD
Moclobemide—Rash—Thiotepa—sarcoma	0.00279	0.00288	CcSEcCtD
Moclobemide—Dermatitis—Thiotepa—sarcoma	0.00278	0.00288	CcSEcCtD
Moclobemide—Headache—Thiotepa—sarcoma	0.00277	0.00287	CcSEcCtD
Moclobemide—Rash—Dactinomycin—sarcoma	0.00276	0.00286	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—sarcoma	0.00276	0.00286	CcSEcCtD
Moclobemide—Asthenia—Mitoxantrone—sarcoma	0.00274	0.00283	CcSEcCtD
Moclobemide—Fatigue—Etoposide—sarcoma	0.00274	0.00283	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—sarcoma	0.00272	0.00281	CcSEcCtD
Moclobemide—Constipation—Etoposide—sarcoma	0.00271	0.00281	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—sarcoma	0.00271	0.00281	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—sarcoma	0.00271	0.0028	CcSEcCtD
Moclobemide—Diarrhoea—Vincristine—sarcoma	0.00268	0.00278	CcSEcCtD
Moclobemide—Sweating—Epirubicin—sarcoma	0.00267	0.00277	CcSEcCtD
Moclobemide—Nausea—Thiotepa—sarcoma	0.00262	0.00272	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—sarcoma	0.00262	0.00271	CcSEcCtD
Moclobemide—Diarrhoea—Mitoxantrone—sarcoma	0.00261	0.0027	CcSEcCtD
Moclobemide—Nausea—Dactinomycin—sarcoma	0.0026	0.0027	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—sarcoma	0.0026	0.00269	CcSEcCtD
Moclobemide—Dizziness—Vincristine—sarcoma	0.00259	0.00268	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—sarcoma	0.00258	0.00267	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—sarcoma	0.00255	0.00264	CcSEcCtD
Moclobemide—Urticaria—Etoposide—sarcoma	0.00252	0.00261	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—sarcoma	0.00252	0.0026	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—sarcoma	0.00251	0.0026	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—sarcoma	0.00251	0.0026	CcSEcCtD
Moclobemide—Vomiting—Vincristine—sarcoma	0.00249	0.00258	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—sarcoma	0.00247	0.00256	CcSEcCtD
Moclobemide—Rash—Vincristine—sarcoma	0.00247	0.00256	CcSEcCtD
Moclobemide—Dermatitis—Vincristine—sarcoma	0.00247	0.00255	CcSEcCtD
Moclobemide—Headache—Vincristine—sarcoma	0.00245	0.00254	CcSEcCtD
Moclobemide—Vomiting—Mitoxantrone—sarcoma	0.00243	0.00251	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—sarcoma	0.00241	0.0025	CcSEcCtD
Moclobemide—Rash—Mitoxantrone—sarcoma	0.00241	0.00249	CcSEcCtD
Moclobemide—Dermatitis—Mitoxantrone—sarcoma	0.0024	0.00249	CcSEcCtD
Moclobemide—Headache—Mitoxantrone—sarcoma	0.00239	0.00247	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—sarcoma	0.00236	0.00244	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—sarcoma	0.00233	0.00242	CcSEcCtD
Moclobemide—Nausea—Vincristine—sarcoma	0.00233	0.00241	CcSEcCtD
Moclobemide—Flushing—Epirubicin—sarcoma	0.00232	0.00241	CcSEcCtD
Moclobemide—Asthenia—Etoposide—sarcoma	0.00228	0.00236	CcSEcCtD
Moclobemide—Nausea—Mitoxantrone—sarcoma	0.00227	0.00235	CcSEcCtD
Moclobemide—Pruritus—Etoposide—sarcoma	0.00225	0.00232	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—sarcoma	0.00223	0.00231	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—sarcoma	0.00217	0.00225	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—sarcoma	0.00216	0.00224	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—sarcoma	0.00215	0.00223	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—sarcoma	0.00215	0.00222	CcSEcCtD
Moclobemide—Tension—Epirubicin—sarcoma	0.00214	0.00221	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—sarcoma	0.00213	0.00221	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—sarcoma	0.00212	0.00219	CcSEcCtD
Moclobemide—Dizziness—Etoposide—sarcoma	0.0021	0.00217	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—sarcoma	0.00205	0.00213	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—sarcoma	0.00202	0.00209	CcSEcCtD
Moclobemide—Vomiting—Etoposide—sarcoma	0.00202	0.00209	CcSEcCtD
Moclobemide—Agitation—Epirubicin—sarcoma	0.002	0.00207	CcSEcCtD
Moclobemide—Rash—Etoposide—sarcoma	0.002	0.00207	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—sarcoma	0.002	0.00207	CcSEcCtD
Moclobemide—Headache—Etoposide—sarcoma	0.00199	0.00206	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—sarcoma	0.00199	0.00206	CcSEcCtD
Moclobemide—Tension—Doxorubicin—sarcoma	0.00198	0.00205	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—sarcoma	0.00198	0.00204	CcSEcCtD
Moclobemide—Malaise—Epirubicin—sarcoma	0.00197	0.00203	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—sarcoma	0.00196	0.00203	CcSEcCtD
Moclobemide—Syncope—Epirubicin—sarcoma	0.00195	0.00202	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—sarcoma	0.00193	0.00199	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—sarcoma	0.00192	0.00198	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—sarcoma	0.0019	0.00197	CcSEcCtD
Moclobemide—Nausea—Etoposide—sarcoma	0.00189	0.00195	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—sarcoma	0.00188	0.00195	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—sarcoma	0.00187	0.00194	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—sarcoma	0.00186	0.00192	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—sarcoma	0.00186	0.00192	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—sarcoma	0.00185	0.00192	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—sarcoma	0.00185	0.00191	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—sarcoma	0.00183	0.0019	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—sarcoma	0.00182	0.00188	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—sarcoma	0.00181	0.00188	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—sarcoma	0.00181	0.00187	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—sarcoma	0.00179	0.00186	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—sarcoma	0.00178	0.00185	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—sarcoma	0.00177	0.00184	CcSEcCtD
Moclobemide—Shock—Epirubicin—sarcoma	0.00175	0.00181	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—sarcoma	0.00174	0.0018	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—sarcoma	0.00174	0.0018	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—sarcoma	0.00172	0.00178	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—sarcoma	0.00172	0.00178	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—sarcoma	0.00172	0.00178	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—sarcoma	0.00171	0.00177	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—sarcoma	0.0017	0.00176	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—sarcoma	0.00168	0.00174	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—sarcoma	0.00166	0.00172	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—sarcoma	0.00166	0.00172	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00162	0.00168	CcSEcCtD
Moclobemide—Shock—Doxorubicin—sarcoma	0.00162	0.00168	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—sarcoma	0.00161	0.00167	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—sarcoma	0.00161	0.00166	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—sarcoma	0.0016	0.00165	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—sarcoma	0.00159	0.00165	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—sarcoma	0.00159	0.00164	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—sarcoma	0.00158	0.00164	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—sarcoma	0.00157	0.00162	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—sarcoma	0.00155	0.0016	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—sarcoma	0.00154	0.00159	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—sarcoma	0.00153	0.00159	CcSEcCtD
Moclobemide—Constipation—Epirubicin—sarcoma	0.00152	0.00157	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.0015	0.00155	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—sarcoma	0.00149	0.00154	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—sarcoma	0.00148	0.00153	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—sarcoma	0.00147	0.00152	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—sarcoma	0.00147	0.00152	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—sarcoma	0.00146	0.00151	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—sarcoma	0.00145	0.00151	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—sarcoma	0.00145	0.0015	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—sarcoma	0.00143	0.00148	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—sarcoma	0.00142	0.00147	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—sarcoma	0.00141	0.00146	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—sarcoma	0.00141	0.00146	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—sarcoma	0.00141	0.00146	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—sarcoma	0.00136	0.0014	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—sarcoma	0.00135	0.00139	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—sarcoma	0.00131	0.00135	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—sarcoma	0.0013	0.00135	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—sarcoma	0.00128	0.00132	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—sarcoma	0.00126	0.0013	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—sarcoma	0.00122	0.00126	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—sarcoma	0.00118	0.00122	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—sarcoma	0.00118	0.00122	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—sarcoma	0.00116	0.00121	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—sarcoma	0.00113	0.00117	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—sarcoma	0.00113	0.00117	CcSEcCtD
Moclobemide—Rash—Epirubicin—sarcoma	0.00112	0.00116	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—sarcoma	0.00112	0.00116	CcSEcCtD
Moclobemide—Headache—Epirubicin—sarcoma	0.00111	0.00115	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—sarcoma	0.00109	0.00113	CcSEcCtD
Moclobemide—Nausea—Epirubicin—sarcoma	0.00106	0.00109	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—sarcoma	0.00105	0.00108	CcSEcCtD
Moclobemide—Rash—Doxorubicin—sarcoma	0.00104	0.00107	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—sarcoma	0.00104	0.00107	CcSEcCtD
Moclobemide—Headache—Doxorubicin—sarcoma	0.00103	0.00107	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—sarcoma	0.000978	0.00101	CcSEcCtD
